Total Pancreatectomy and Islet Auto Transplant for Chronic Pancreatitis. Read more about Total Pancreatectomy and Islet Auto Transplant for Chronic Pancreatitis.
Tu1008: FACTORS ASSOCIATED WITH COLONOSCOPY NO-SHOW IN PATIENTS WITH AND WITHOUT A PREVIOUS MISSED COLONOSCOPY. Read more about Tu1008: FACTORS ASSOCIATED WITH COLONOSCOPY NO-SHOW IN PATIENTS WITH AND WITHOUT A PREVIOUS MISSED COLONOSCOPY.
Su1015: CHARACTERISTICS AND OUTCOMES OF ABNORMAL FECAL IMMUNOCHEMICAL TESTS (FIT) IN PATIENTS LINKED AND NOT LINKED TO PRIMARY CARE IN A SAFETY-NET HEALTH SYSTEM. Read more about Su1015: CHARACTERISTICS AND OUTCOMES OF ABNORMAL FECAL IMMUNOCHEMICAL TESTS (FIT) IN PATIENTS LINKED AND NOT LINKED TO PRIMARY CARE IN A SAFETY-NET HEALTH SYSTEM.
Su1010: INFLUENCE OF COMORBIDITIES ON COLORECTAL CANCER SCREENING PARTICIPATION AND MORTALITY. Read more about Su1010: INFLUENCE OF COMORBIDITIES ON COLORECTAL CANCER SCREENING PARTICIPATION AND MORTALITY.
Mo1030: SOCIAL DETERMINANTS OF ENDOSCOPY COMPLETION IN A SAFETY NET HOSPITAL. Read more about Mo1030: SOCIAL DETERMINANTS OF ENDOSCOPY COMPLETION IN A SAFETY NET HOSPITAL.
Mo1835: POST-VACCINATION SARS-COV-2 NEUTRALIZING ANTIBODIES IN A COHORT OF PREGNANT WOMEN RECEIVING BIOLOGICS FOR INFLAMMATORY BOWEL DISEASE. Read more about Mo1835: POST-VACCINATION SARS-COV-2 NEUTRALIZING ANTIBODIES IN A COHORT OF PREGNANT WOMEN RECEIVING BIOLOGICS FOR INFLAMMATORY BOWEL DISEASE.
Human Hepatocytes Can Give Rise to Intrahepatic Cholangiocarcinomas. Read more about Human Hepatocytes Can Give Rise to Intrahepatic Cholangiocarcinomas.
Tu1756 TWO SPATIAL TRANSCRIPTOMIC PLATFORMS IDENTIFIED POTENTIAL PATHWAYS LINKED TO VEDOLIZUMAB RESPONSIVENESS IN ULCERATIVE COLITIS. Read more about Tu1756 TWO SPATIAL TRANSCRIPTOMIC PLATFORMS IDENTIFIED POTENTIAL PATHWAYS LINKED TO VEDOLIZUMAB RESPONSIVENESS IN ULCERATIVE COLITIS.
Mo1866 REAL WORLD EFFICACY OF RISANKIZUMAB IN CROHN'S DISEASE PATIENTS WITH PRIOR EXPOSURE TO USTEKINUMAB. Read more about Mo1866 REAL WORLD EFFICACY OF RISANKIZUMAB IN CROHN'S DISEASE PATIENTS WITH PRIOR EXPOSURE TO USTEKINUMAB.
Mo1022 ELECTRONIC CODING FOR ABNORMAL FECAL IMMUNOCHEMICAL TEST IS ASSOCIATED WITH INCREASED COLONOSCOPY COMPLETION. Read more about Mo1022 ELECTRONIC CODING FOR ABNORMAL FECAL IMMUNOCHEMICAL TEST IS ASSOCIATED WITH INCREASED COLONOSCOPY COMPLETION.
